Neurology News
Infantile Spasms: Collaborating for Awareness, Management, and Education [World Neurology 39:3 Editor's Choice]
26 Jul 2024
Partnerships could lead to new treatments and improved patient care.
Is endocrine surveillance important in the care of Duchenne Muscular Dystrophy? [eNS36 Editor's Choice]
24 Jul 2024
Results from a national survey to patients and families on endocrine complications
From Animal Spirits to Brain-Computer Interface [World Neurology 39:3 Editor's Choice]
18 Jul 2024
A look back at the relationship between electricity and the brain on the 100th anniversary of the first human EEG recording.
Effects of vaccination on COVID-19 infection symptoms in multiple sclerosis patients [eNS36 Editor's Choice]
15 Jul 2024
This study emphasizes the importance of COVID-19 vaccination for MS patients, due to its potential to reduce symptoms.
Nocturnal heat exposure and stroke risk
11 Jul 2024
In recent decades, nighttime temperatures have increased faster than daytime temperatures. The increasing prevalence of nocturnal heat exposure may pose a significant risk to cardiovascular health. This study investigated the association between nighttime heat exposure and stroke risk in the region of Augsburg, Germany, and examined its temporal variations over 15 years.
Optimised Diagnosis of Neuroborreliosis. Signalling Protein as a Biomarker.
10 Jul 2024
A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis. The clinical diagnosis of this disease, which is caused by infections from tick bites, is still difficult and often occurs long after infection. CXCL13 now makes it possible to diagnose neuroborreliosis more quickly and start treatment earlier. In the study conducted by the Karl Landsteiner University of Health Sciences (KL Krems), a concentration of CXCL13 in the cerebrospinal fluid of > 271 pg/ml was identified with a very high statistical certainty as the threshold value for a better diagnosis of neuroborreliosis.
WHO launches new toolkit to improve care for neurological disorders
8 Jul 2024
WHO has today published a new implementation toolkit to the Intersectoral global action plan on epilepsy and other neurological disorders (IGAP), outlining specific actions and resources for countries to improve services for people with neurological disorders in preparation for meeting IGAP’s targets for 2031.
Learn About The New Global Advocacy Leadership Program
28 Jun 2024
Applications are now open for the Global Advocacy Leadership Program, a unique new opportunity from the AAN and the World Federation of Neurology (WFN)
eNeurologicalSci (eNS) June 2024 issue
28 Jun 2024
The WFN June 2024 issue of the OPEN ACCESS journal eNeurologicalSci Vol. 35 is now available online.
Typical and atypical MRI abnormalities in Wernicke's encephalopathy:Correlation with blood vitamin B1 levels [Editors Choice]
15 Jun 2024
Clinical features of Wernicke's encephalopathy (WE) confirmed strictly through the low blood vitamin B1 (VB1) levels are limited. This study aimed to analyse magnetic resonance imaging (MRI) findings, and clinical characteristics, in patients with WE who have confirmed low blood VB1 levels.
Web design by Tribal Systems